Omnicell financials
$34.31+1.30%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $312.2M | $309.9M | $314.0M | $310.6M | $290.6M | $269.7M | $306.9M | $282.4M | $276.8M | $246.2M | $258.8M | $298.7M |
| Gross profit | $152.9M | $140.4M | $130.3M | $134.5M | $127.7M | $110.9M | $141.8M | $122.3M | $114.4M | $92.6M | $105.4M | $132.0M |
| Gross margin | 49.0% | 45.3% | 41.5% | 43.3% | 43.9% | 41.1% | 46.2% | 43.3% | 41.3% | 37.6% | 40.7% | 44.2% |
| Operating income | $32.4M | $16.9M | $415.0K | $8.2M | $8.1M | -$11.6M | $12.4M | $6.6M | $3.2M | -$21.8M | -$23.4M | $3.7M |
| Net income | $24.3M | $11.4M | -$2.0M | $5.5M | $5.6M | -$7.0M | $15.8M | $8.6M | $3.7M | -$15.7M | -$14.4M | $5.6M |
| Net margin | 7.8% | 3.7% | −0.6% | 1.8% | 1.9% | −2.6% | 5.2% | 3.1% | 1.3% | −6.4% | −5.6% | 1.9% |
| Diluted EPS | $0.52 | $0.25 | $-0.04 | $0.12 | $0.12 | $-0.15 | $0.34 | $0.19 | $0.08 | $-0.34 | $-0.32 | $0.12 |
| EBITDA | $51.3M | $35.4M | $20.2M | $27.6M | $27.7M | $8.4M | $32.4M | $26.7M | $24.1M | -$594.0K | -$23.4M | $25.3M |
| Operating cash flow | $68.3M | $54.5M | $30.4M | $28.3M | $42.8M | $25.9M | $56.3M | $22.8M | $58.7M | $50.0M | $38.4M | $57.0M |
| Free cash flow | $59.4M | $42.1M | $22.6M | $18.5M | $31.0M | $14.8M | $47.2M | $13.9M | $52.5M | $37.6M | $15.8M | $46.4M |
| Diluted shares | 46.3M | 45.9M | 46.0M | 45.9M | 47.0M | 46.6M | 46.8M | 46.4M | 46.0M | 45.7M | 44.9M | 45.6M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $292.2M | $239.2M | $196.5M | $180.1M | $399.0M | $386.8M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $168.2M | $167.9M | $167.6M | $167.3M | $341.8M | $341.3M |
| Total assets | $2.00B | $2.00B | $1.97B | $1.95B | $2.15B | $2.15B |
| Total liabilities | $707.3M | $747.5M | $742.9M | $727.7M | $881.9M | $894.4M |
| Shareholders' equity | $1.29B | $1.26B | $1.23B | $1.22B | $1.26B | $1.26B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology